Investegate |Helsinn Healthcare S.A. Announcements | Helsinn Healthcare S.A.: ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan

Helsinn Healthcare S.A.
ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
  
 
ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
Not intended for US media
Lugano, Switzerland, and Osaka, Japan, January 22, 2021 - Helsinn Group (Lugano, Switzerland; CEO: Riccardo Braglia, “Helsinn”) and Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and Representative Director: Gyo Sagara; “ONO”) announced today that ONO received the manufacturing and marketing approval of Adlumiz® (generic name: anamorelin hydrochloride) Tablet 50mg (“Adlumiz”), a ghrelin receptor agonist, for the treatment of cancer cachexia in malignant tumors of non-small cell lung cancer, gastric cancer, pancreatic cancer or colorectal cancer in Japan.

Related Keywords

Taiwan ,Lugano ,Ticino ,Switzerland ,Osaka ,Japan ,South Korea ,Japanese ,Kiyoaki Idemitsu ,Paola Bonvicini ,Riccardo Braglia ,Gyo Sagara ,Helsinn Investment Fund ,Helsinn Group Vice ,Swiss Pharma Company ,China Helsinn Pharmaceuticals ,Group Head Of Communication ,Helsinn Group Media Contact ,Ono Pharmaceutical Co Ltd ,Helsinn Group ,Helsinn Group Lugano ,Ireland Helsinn Birex Pharmaceuticals ,Clinical Development ,Marketing Approval ,Ghrelin Receptor Agonist ,Cancer Cachexia ,Representative Director ,Helsinn Group Vice Chairman ,Corporate Executive Officer ,Executive Director ,Management Plan ,Helsinn Healthcare ,Helsinn Therapeutics ,Helsinn Pharmaceuticals China ,Helsinn Advanced Synthesis ,Helsinn Birex Pharmaceuticals ,Investegate Announcements ,Investegate Company Announcements ,Helsinn Healthcare Sa ,Globe Newswire ,Globenewswire And ,Gnw ,டைவாந் ,லுகானோ ,டிசினோ ,சுவிட்சர்லாந்து ,ஒசகக ,ஜப்பான் ,தெற்கு கொரியா ,ஜப்பானிய ,க்யோ சாகரா ,சுவிஸ் பார்மா நிறுவனம் ,குழு தலை ஆஃப் தொடர்பு ,ஓனோ மருந்து இணை லிமிடெட் ,மருத்துவ வளர்ச்சி ,சந்தைப்படுத்தல் ஒப்புதல் ,பிரதிநிதி இயக்குனர் ,பெருநிறுவன நிர்வாகி அதிகாரி ,நிர்வாகி இயக்குனர் ,மேலாண்மை திட்டம் ,கன்வ் ,